Taiwan has achieved its goal in eliminating hepatitis C ahead of schedule, reaching its target by the end of 2025 after a decade of effort, according to a CNA report. The Health Ministry submitted an application for certification to the World Health Organization (WHO) earlier this year, though the process is still under internal review. Taiwan plans to present its achievements at a side event during the World Health Assembly (WHA) in Geneva, engaging with international experts. 

The WHO set a global target in 2016 to eliminate viral hepatitis by 2030. Taiwan announced last year that it had already met key benchmarks, including diagnosis and treatment rates exceeding 90%. Taiwan has applied for certification through the WHO Western Pacific Regional Office, with results pending expert evaluation. If approved, Taiwan would become the first in Asia to reach this milestone, alongside countries such as Iceland, Australia, and Egypt. 

During the upcoming WHA, Taiwan will host an international hepatitis C forum in Geneva on May 19. The event aims to showcase its achievements and foster professional exchange. Authorities also noted that Taiwan’s research has been published in international journals, further highlighting its success.